chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient experienced dizziness, slurred speech, near loss of consciousness, and extreme sweat within five minutes of administration of the vaccine.  Patient lay down and the symptoms faded within another five to ten minutes.  A regular dose of an antihistamine was administered when the symptoms were present.
face swelling, vomiting, diarrhea, itching & SOB w/in 15min of vax;recv tx emergency dept of epi, DPH;all sx resolved;
I had a regular appointment with my doctor and that?s when I told him that my arm was hurting, and he said that I had to go to physical therapy. He did not prescribed any medications or do any tests
She can't chew on the left side of the face near her chin; it hurts when she swallows near the neck area; This spontaneous case was reported by a consumer and describes the occurrence of MASTICATION DISORDER (She can't chew on the left side of the face near her chin) and ODYNOPHAGIA (it hurts when she swallows near the neck area) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), METOPROLOL, nortriptyline (Pamelor                                                        ), AMLODIPINE, HYDROCODONE and ACETAMINOPHEN for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced MASTICATION DISORDER (She can't chew on the left side of the face near her chin) and ODYNOPHAGIA (it hurts when she swallows near the neck area). At the time of the report, MASTICATION DISORDER (She can't chew on the left side of the face near her chin) and ODYNOPHAGIA (it hurts when she swallows near the neck area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included None.
This spontaneous report as received from a registered pharmacist refers to a patient of unknown age. The patient was inadvertently vaccinated with a 0.5 ml dose of PNEUMOVAX23 (lot # 667912/0933Z expiration date 25-FEB-2012) IM on 05-SEP-2012. No adverse effects were reported. Additional information has been requested.
this was my third dose First time I got "covid arm, heat, awful swelling  THEN suddenly I got  terrible allergic reaction to a bee sting.   REALLY bad. I Have never been allergic before, I still have a raised scar weeks later   N OW my Inflammatory arthritis iS CRAZY INFLAMMED AND HORRIBLY PAINFUL LIKE BEVER BEFORE
When I had my first and second shots, I felt uncomfortable with some warm feeling, but became fine after one day. When I had the booster shot, I had the similar uncomfortable feeling on Nov. 17, but could start working on the Nov. 18. However, on Nov. 19, I felt some muscle tightness and mild pain inside the left chest, and it is still there today.  Then on Nov. 20, some areas (about a quarter size) beneath the left nibble became red with appearance similar to herpes.
Patient ID: 44 y.o.    Admit Date:  8/12/2022   Discharge Date:   8/14/2022   Discharge Diagnosis:  Principal Problem:   Acute hypoxemic respiratory failure due to COVID-19 Active Problems:   Hypokalemia   Hyponatremia     Hospital Course:  44 year old vaccinated female was admitted for Covid-19 infection and hyponatremia. She was treated with Remdesivir and IV fluids. Na has improved to 129 from 120. She will be discharged home today in stable condition. D dimer remains elevated and she will be on ASA. Patient educated on appropriate level of care post-discharge. Follow up with Primary Care Doctor in 5-7 days.   Physical Exam on the day of discharge: Last Recorded Vital Signs: Temp: 98.2 °F (36.8 °C) Heart Rate (Monitor): 88 Pulse: 82 BP: 108/70 Respirations: 18 SpO2: 100 % O2 Flow Rate (l/min): 2 l/min General Appearance: no distress  Eyes: PERRLA ENT: moist mucus membranes, no adenopathy Lungs: clear to auscultation bilaterally  Heart: regular rate and rhythm Abdomen: soft, non-tender  Skin: No rashes or lesions  Extremities: full ROM Neuro: alert, normal strength and tone    Consults:  IP CONSULT TO NEPHROLOGY   Significant Diagnostic Studies:   CT head   Operations: none   Disposition:  Home    Discharge Condition:  Fair
This spontaneous report as received from a Licensed Practical Nurse refers to an unspecified number of patients of unknown age and gender. Information regarding the patients' medical history, concurrent condition and concomitant medication was not reported. On unknown dates in 2016 (reported as since 01-JAN-2016), the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (dose and route of administration were not reported, lot# L044917 with expiration date of 05-OCT-2018 and lot# L010595 with expiration date of 12-NOV-2016). No adverse effects had been reported. The RECOMBIVAX HB vaccines underwent a temperature excursion of -3 Celsius degrees for 19 hours. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient reported swelling, redness, and itching around the vaccination site, starting the day after administration and subsiding after 3 days.
33 year old male with no past medical history received second dose of moderna shot 9/20/21 AM. Started feeling short of breath a few hours later. By the evening, patient experienced chest pain causing patient to seek medical attention at nearest emergency department. Patient was given 4 aspirin and pain was relieved. Troponin on arrival was 1.4 and peaked at 2.4. EKG NSR, ECHO normal. Chest xray normal. Pt diagnosed myocarditis and was admitted to hospital overnight for monitoring
saw a lump on his heel that wasn't there before; a lump on his heel, it is swollen it happened right after the shot; he was walking with a limp/he couldn't walk out fine; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EN6199), via an unspecified route of administration on 04Mar2021 as single dose for COVID-19 immunisation/to stay alive and not get sick. There was no medical history and no concomitant medications. The patient reported that he received his first covid vaccine dose yesterday, he waited the 15 minutes which was recommended after getting the vaccine and when he got up to leave and walk out he felt like his sock had rolled up on his foot and he was walking with a limp on 04Mar2021. Patient reported that he took his shoe off and saw a lump on his heel that wasn't there before. His heel was bothering him so he checked to see if there was something stuck in his shoe like a rock or whatever and he found nothing and he kept walking and it was getting worse to he checked again and still found nothing and he was just curious, he has read all the paper work and cannot find anything with issues like this with a lump on his heel, it was swollen and it happened right after the shot. He asked if he was daydreaming or has there been anything like this with other people. He reported that he has never had this before and it was all of a sudden he walked in fine but he couldn't walk out fine, it was strange. Patient was asking if this was normal or something that has been reported. Outcome of events was not recovered.
At approximately 1825 a patient fainted over in her seat at the observation area. The EMS transported her to the other side of the gymnasium wherea privacy screen is set up. She was fine to leave around 1835 per the EMT but stayed till 1848 and left on her own will. Patient was 16 years of age, female. Girl has a history of passing out, i.e. when she received novocaine and when she got her ears pierced. Her guardian declined to give a name for the report.
Extreme left shoulder pain/burning - 48hrs Swollen, very painful lymph nodes in the left armpit- 10 days Headache - 4 days
1/25/23 @ 11:00pm Pt felt lightheaded w/ severe headache. She said her legs felt like they would give out. She felt weak w/ low energy on 1/26/23. All symptoms resolved by 1/27/23 w/ no treatment.
Moderna CoVIS-19 Vaccine EUA At the injection site on my left arm, the muscle is swollen, red, and rock hard.
Few leaks may have dropped out during administration; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number Z4G559, expiry date 7th July 2023) for prophylaxis.   On 16th June 2022, the patient received Shingrix. On 16th June 2022, unknown after receiving Shingrix, the patient experienced incomplete dose administered. On an unknown date, the outcome of the incomplete dose administered was unknown.   Additional Information: GSK Receipt Date: 17-Jun-2022 Reporter's comments: The patient received a Shingrix in left deltoid that a few leaks might have dropped out during administration. Additional Supportive Information: While receiving Shingrix, few leaks might have dropped out, which led to incomplete dose administered.
could not bend her middle finger; excruciating pain to bend her other fingers, felt like fingers bruised or broken; injection site warm; rash kept spreading across arm; injection site hard; injection site rash; rash getting darker red; This spontaneous case was reported by a consumer and describes the occurrence of EXTREMITY CONTRACTURE (could not bend her middle finger), PAIN IN EXTREMITY (excruciating pain to bend her other fingers, felt like fingers bruised or broken), VACCINATION SITE WARMTH (injection site warm), RASH (rash kept spreading across arm) and VACCINATION SITE INDURATION (injection site hard) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042BZ1A and 021BZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced EXTREMITY CONTRACTURE (could not bend her middle finger), PAIN IN EXTREMITY (excruciating pain to bend her other fingers, felt like fingers bruised or broken), VACCINATION SITE WARMTH (injection site warm), RASH (rash kept spreading across arm), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE RASH (injection site rash) and VACCINATION SITE ERYTHEMA (rash getting darker red). At the time of the report, EXTREMITY CONTRACTURE (could not bend her middle finger), PAIN IN EXTREMITY (excruciating pain to bend her other fingers, felt like fingers bruised or broken), VACCINATION SITE WARMTH (injection site warm), RASH (rash kept spreading across arm), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE RASH (injection site rash) and VACCINATION SITE ERYTHEMA (rash getting darker red) outcome was unknown.            No concomitant medications were reported. No treatment was reported. Action taken with mRNA-1273 in response to the events was not Applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-101654 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-101654:Crosslinked case
No adverse event; Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms; 42 patients received Bivalent Boosters with 38 having improvement of symptoms of 50 percent or more; This spontaneous case was reported by a physician and describes the occurrence of OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms), THERAPEUTIC RESPONSE UNEXPECTED (42 patients received Bivalent Boosters with 38 having improvement of symptoms of 50 percent or more) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for Long COVID.     No Medical History information was reported.    In 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2023, the patient experienced OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms) and THERAPEUTIC RESPONSE UNEXPECTED (42 patients received Bivalent Boosters with 38 having improvement of symptoms of 50 percent or more). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms), THERAPEUTIC RESPONSE UNEXPECTED (42 patients received Bivalent Boosters with 38 having improvement of symptoms of 50 percent or more) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms) and THERAPEUTIC RESPONSE UNEXPECTED (42 patients received Bivalent Boosters with 38 having improvement of symptoms of 50 percent or more).    Concomitant medication was not reported.  Vaccine was given to patients for long COVID between Mar-2023 and 01-Aug-2023. 42 patients received Bivalent Boosters with 38 having improvement of symptoms of 50 percent or more. Vaccine was given within current guidelines except seven were under 65. Patients were treated with skin lesions, brain, SBP 220, Tachycardia greater than or equal to 150 and body aches. Treatment medication was not reported.  This case contains information of 5th patient out of 42 reported by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-735199 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735199:Master case
Patient felt a swollen lymph node that was causing pain the next day after being vaccinated on the same arm. The patient was instructed to see her primary doctor. The physician did not believe the swollen lymph node was associated to the vaccine. The patient was asked to place a warm compress on the area and take TYLENOL.
AFTER RECEIVING THE VACCINE, SHE VOMITTED. ON SITE EMS RESPONDED. VITALS LISTED BELOW. SHE FELT BETTER AND WAS RELEASED TO HOME
This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a male patient of unknown age. Medical history and concomitant medications were not provided. On or about 29-SEP-2014, the patient was vaccinated with ZOSTAVAX at a pharmacy as recommended for routine health maintenance for the prevention of shingles (route and lot # not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 02-MAY-2016, the patient was treated by Nurse Practitioner for a painful rash that had spread into the ear and caused hearing loss. The condition was diagnosed as shingles. He was evaluated by an Audiology specialist to confirm the hearing loss. On or about 14-SEP-2016, the patient was treated at a facility for a shingles attack that was treated by two physicians. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. The outcome was unknown. Upon internal review, shingles that caused hearing loss was considered medically significant. Additional information has been requested.
That night I laid down and went to bed but as I was falling asleep my heart felt strange but it didn't last long so I went to sleep. The next morning, I listened to my heart with a stethoscope and noticed 2 or 3 distinct skipped beats per minute. I emailed my doctor who reached out to confirm that there were no other concerning symptoms associated. By 5/11, I was feeling a lot of strange sensation in my chest. Since I've never had an issue like this in the past, I called my doctor again and made an appointment on 5/12 to see a doctor at my PCPs office. He did a chest xray and an ekg. He stated that I was probably experiencing some mild inflammation due to the vaccine. I felt better for a few days but on Monday, 5/16 the sensation in my chest returned and I was hearing at least 4 skipped beats per minute. I called my doctor again and I'm scheduled to do a holter monitor starting on 5/26 for further diagnosis.
I am an investigator with the coroner's office. We have a death that occurred on 4/12/2021 that we ruled a natural death due to atherosclerotic cardiovascular disease. The family is concerned that the decedent was doing "fine" until she took the J&J COVID-19 vaccine on April 9, 2021.  We DO NOT KNOW if the J&J vaccine caused this death, but are reporting it due to the close proximity of the vaccination to the death itself.
He got shots in both legs(2) one leg is swollen. He was running fever last night . Also throwing up.
The patient presented to the ED by EMS on 2/9/23 for evaluation of numbness in her feet, fever, mild cough, chills, and shortness of breath. She was recently admitted to the hospital (2/1-2/6) for severe sepsis secondary to left lower extremity cellulitis, and there was concern of recurring infection, so she was brough to the ED. In the ED, a COVID PCR test was done which resulted positive. She was admitted 2/9/23-2/14/23. Discharge diagnoses include COVID-19 infection with possible COVID pneumonia, suspected superimposed community-acquired pneumonia, and acute hypoxic respiratory failure related to above, among other diagnoses. She was started on remdesivir on 2/10. The patient required supplemental O2 during admission and was able to be weaned down to room air prior to discharge.  Of note, she has received the primary COVID vaccine series and three boosters.
first SHINGRIX vaccine 2 years ago; Shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received SHINGRIX for prophylaxis. Co-suspect products included Herpes zoster (SHINGRIX) for prophylaxis.   On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml and the 2nd dose of SHINGRIX. On 27th August 2020, unknown after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the patient experienced incomplete course of vaccination. On 10th September 2020, the outcome of the shingles was recovered/resolved. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles to be related to SHINGRIX.  Additional details were provided as follows:  The age at vaccination was not applicable for 2nd dose of SHINGRIX.  Till the time of reporting, patient did not received 2nd dose of SHINGRIX, which led to incomplete course of vaccination. The patient received 1st dose of SHINGRIX and experienced shingles 5 weeks ago which lasted for 3 weeks. The reporter did not consented to follow up.
Site of vaccination was uncomfortable immediately following the vaccination, and in the days following developed a red, swollen patch in the vaccination site.
The next day I had an arm pain and I had pain all over my body. When I was at the doctor's office. They ran and EKG. I did not feel well with all the vaccination but the 3rd dose I just couldn't feel my arms at all. I was dizzy and the inside of my throat it was closing, and I couldn't swallow anything. When I went to the emergency room they gave me steroids, but I still don't feel good. The pain is less but it is still there.
Vaccine administered 3d ago. Pt also went to dentist 2d ago. Developed significant, focal lumbar-sacral "spinal pain" 2d ago, worsening. Pt also developed cough.
Pt stated two days after receiving Moderna Covid Booster vaccine, she experienced hypotension, weakness, and dehydration resulting in hospitalization.
Pt awakened @ 830AM day p/vax pt had an intense shiver-like episode which lasted for a few seconds while diapers were being changed; mom said it looked like someone w/epilepsy; t101 R;
Extreme redness, soreness at point of injection - very sore 2/5/21 (more so than right after receiving vaccination)
@ site of injection- large area of erythema and swelling, multiple vesicles @ site and pt c/o pruritus (L arm varicella site)
15:00pm Pt. c/o numbness and tingling of LUE with stiffness. Had note from PCP clearing her to take 2nd dose of vaccine. States he had a previous reaction to the 1st. dose. 15:30pm 110/70 86 16 O2 98%;  15:45pm 100/70 76 16  O297%;  15:10pm Pt. given 5ml diphenhydramine po. 15:46pm Alert and oriented x3, Resp. even and unlabored. Lungs clear. Pt. ambulatory. States relief from S/S. with equal grip.. Capillary refill less than 3 seconds. Positive radial pulse.  Advised to seek immediate medical attention if S/S return. DISPOSITION:  Alert and oriented x3 lungs clear; skin w/o, NAD.
I had a blurred visual disturbance 1 day after received 2nd shot of vaccine and I did last for 5 days. After 5 days it seems to set back to normal slowy.
This spontaneous report was received from a healthcare worker regarding a 4 year old patient of unknown gender. There was no information about concurrent condition and historical medication. On 03-FEB-2016, the 4 year old patient was inadvertently vaccinated with GARDASIL 9 lot # L020015, expiration date 16-AUG-2017. No adverse event was reported. The outcome of the event was unknown. No PQC was involved. Additional information has been requested.
Patient received COVID19 vaccine on 1/26/21 (mfg unknown); headache started 1/27/21 at 2pm.  Patient had headache and tiredness and diarrhea and body aches after 2nd dose covid vaccine.  Symptoms progressed to severe headache associated with N/V, dizziness that started 1/28@0800am.  The patient admitted to Emergency Room at Hospital on 1/28/21 and diagnosed with aneurysmal subarachnoid hemorrhage.  Patient transferred to Medical Center for care.
4 days post vax the pt experienced petechiae on his facial cheeks under his eyes.
Inadvertently administered Moderna as the second dose versus Pfizer which was given as the first dose.
After vaccination, complained of headache, fatigue and nausea with mild jaw tingling.  Attended to with supportive care by onsite paramedic and RN.  Safely discharged home after 20 minutes.
Two days after the shot the patient woke up and had a swollen left arm at the injection site. The patient went to church and was light headed and almost passed out. The patient had a headache and took Excedrin and got some relief. The rash lasted over a week.